Timothy P. Walbert
Chairman, President and Chief Executive Officer
Biopharmaceutical
Horizon Pharma
United States of America
Biography
Tim joined Horizon Pharma in June 2008 as president and chief executive officer and has served as chairman of our board of directors since 2010. Prior to joining Horizon Pharma plc, he served as president, chief executive officer and director of IDM Pharma, Inc., a public biopharmaceutical company which was acquired by Takeda America Holdings, Inc., or Takeda, in June 2009.
Research Interest
Pharmaceutical research work
